BR100 Increased By (0.34%)
BR30 Increased By (0.77%)
KSE100 Increased By (0.26%)
KSE30 Increased By (0.25%)
BECO 5.73 Increased By ▲ 0.34 (6.31%)
BML 57.30 Decreased By ▼ -0.16 (-0.28%)
BOP 36.77 Increased By ▲ 0.46 (1.27%)
CNERGY 8.39 Increased By ▲ 0.18 (2.19%)
DCL 12.04 Increased By ▲ 0.21 (1.78%)
FCCL 58.61 Decreased By ▼ -0.67 (-1.13%)
FCSC 5.01 No Change ▼ 0.00 (0%)
FFL 17.94 Increased By ▲ 0.09 (0.5%)
FNEL 1.26 No Change ▼ 0.00 (0%)
HUMNL 11.42 Decreased By ▼ -0.08 (-0.7%)
KEL 8.29 Decreased By ▼ -0.04 (-0.48%)
KOSM 6.62 Decreased By ▼ -0.01 (-0.15%)
MLCF 108.29 Increased By ▲ 0.86 (0.8%)
NBP 206.04 Increased By ▲ 1.03 (0.5%)
PACE 11.17 Increased By ▲ 0.07 (0.63%)
PAEL 45.35 Decreased By ▼ -0.07 (-0.15%)
PIAHCLA 30.77 Decreased By ▼ -0.99 (-3.12%)
PIBTL 19.06 Increased By ▲ 0.21 (1.11%)
PPL 245.95 Increased By ▲ 2.21 (0.91%)
PRL 36.08 Decreased By ▼ -0.16 (-0.44%)
PTC 72.36 Increased By ▲ 0.29 (0.4%)
SEARL 96.67 Increased By ▲ 2.09 (2.21%)
SSGC 31.67 Decreased By ▼ -0.18 (-0.57%)
TELE 9.27 Increased By ▲ 0.25 (2.77%)
THCCL 67.81 Decreased By ▼ -0.66 (-0.96%)
TPLP 11.23 Increased By ▲ 0.51 (4.76%)
TREET 25.89 No Change ▼ 0.00 (0%)
TRG 67.84 Increased By ▲ 3.53 (5.49%)
WAVES 10.98 Increased By ▲ 0.07 (0.64%)
WTL 1.28 Decreased By ▼ -0.01 (-0.78%)
By

BEIJING: Pakistan, China will jointly build a cancer medical laboratory through cooperative partnership.

In this connection, an agreement’s signing ceremony of Pakistan-China biotechnology strategic cooperation was held here, Gwadar Pro reported on Tuesday. Under the flagship project of this cooperation, Pakistani and Chinese companies will jointly build a cancer medical laboratory. The agreement was jointly initiated and signed by Life Rehealth Technology Pakistan and Beijing Anlong Gene Medicine Technology.

Under the proposed framework, Pakistani and Chinese companies will jointly carry out exploration and research on cancer medical treatment, and Chinese companies will also share their existing medical technologies with Pakistan.

Dr Ahmed Waqas, the CEO of Life Rehealth, has been active in CPEC medical cooperation for a long-term. He said in an exclusive interview that, the incidence of cancer in Pakistan is very high, especially lung cancer, liver cancer and so on. However, due to the current medical level and sanitary conditions, patients cannot receive good treatments. Therefore, cooperation between Pakistan and China in this sector is very necessary and will bring great benefits to Pakistan.

Regarding the reasons why Pakistan chose Chinese company as cooperative partner, Waqas said, the cooperation in medical field is of great importance and requires profound friendship and trust between the two sides.

Comments

Comments are closed for this article.